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Vitamin D and calcium play major roles in our bone health in addition to roles in
tissues and cells. These roles in tissues and cells are associated with some cancers. The
purpose of this study was to determine attitudes of cancer patients towards their dietary
intakes of vitamin D and calcium. A questionnaire was completed by 128 volunteers
(mean age=53.5 years±16.6, 94 women, 34 men) from the Montgomery Cancer Clinic in
Montgomery, Alabama. Cancer-reporting participants (n=59) were likely to agree more
(p=0.048) to the statement, “I try to eat healthy every day” compared to non-cancer
reporting participants (n=69) on a 5-point Likert scale; similar results occurred for the
statement, “I have a healthy diet” (p=0.050). Participants without cancer consumed more
fish (salmon, tuna, halibut, etc.) than cancer-reporting participants (p=.035). Women and
cancer-reporting participants were more concerned with eating healthy and obtaining
vitamin D and calcium than non-cancer participants and men.
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CHAPTER I
INTRODUCTION
Cancer is characterized by uncontrolled growth and the spread of abnormal cells
in the body. Cancer is the second leading cause of death among adults in the United
States (heart disease is the leading cause of death). An estimated 577,190 Americans are
expected to die of cancer in 2012, accounting for nearly one of every four deaths. Lung
cancer is the leading cause of cancer death in both men and women followed by prostate
cancer in men and breast cancer in women (American Cancer Society [ACS], 2012).
Overall, approximately 1,638,910 new cancer diagnoses are expected in 2012.
Breast cancer accounts for approximately 30% of new cancer diagnoses in women and is
the second highest cancer diagnosis after basal and squamous cell skin cancers (ACS,
2012). Breast cancer rates began to decline in 2000 (ACS, 2012) and fell by 6.7%
between 2002 and 2003 with little additional decrease in 2004 (Ravdin et al., 2007). The
decrease in breast cancer rates has been attributed to the decrease in the use of hormonereplacement therapy in postmenopausal women (Ravdin et al., 2007).
Although men only have a one in 1,000 chance of developing breast cancer, 410
male breast cancer patients are estimated to die in 2012. In addition to the 410 predicted
deaths among men with breast cancer, 39,920 women with breast cancer are estimated to
die in 2012 (ACS, 2012). While genetics and age play major roles in one’s risk of
developing breast cancer (ACS, 2012), research has shown a relationship of breast cancer
risk and nutrient intakes, specifically vitamin D and calcium (Peterlik & Cross, 2005).
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The American Cancer Society (ACS) (2012) estimated from scientific evidence
that about one-third of all cancer deaths are related to overweight or obesity, physical
inactivity, and poor nutrition and could be prevented. Adequate amounts of vitamin D
and calcium in the diet have been associated with reduced risk of cancer (Lappe, TraversGustafson, Davies, Recker, & Heaney, 2007). According to Neuhouser et al. (2008),
vitamin D influences important cellular events (apoptosis and cell cycle-regulation) that
are critical in cancer patients’ prognosis and survival. Vitamin D and calcium can help
inhibit the growth of mammary tumors and also have a variety of positive functions in
bone diseases. These micronutrients can play a role in a breast cancer patient’s bone
recovery and stability during and after cancer treatments (Peterlik & Cross, 2005).
The purpose of this study was to investigate attitudes of cancer patients towards
their diet and dietary intakes of vitamin D and calcium. The objectives of this study were
to conduct a survey with a group of people that had been diagnosed with cancer and a
control group (participants who had not been diagnosed with cancer) and compare
differences between the two groups, specifically concerning vitamin D and calcium. This
study has the potential to reveal a difference in attitudes and dietary habits concerning
vitamin D and calcium in cancer and non-cancer participants. Future programs for cancer
patients or cancer survivors could possibly use these findings to help develop nutritional
educational content.
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CHAPTER II
REVIEW OF LITERATURE
In the United States, one-third of the expected 577,190 cancer deaths in 2012 will
be attributed to overweight and obesity, physical inactivity, and poor nutrition (ACS,
2012). The estimated cost of cancer in 2007 was $226.8 billion, which included direct
medical cost for all healthcare expenditures for cancer ($103.8 billion), and indirect
mortality cost of $123.0 billion (cost of lost productivity due to premature death caused
by cancer) (ACS, 2012). The ACS (2012) predicts that there will be 1,638,910 new
cancer cases in 2012 along with over a half a million deaths from cancer. Prevention and
treatment can help save lives as well as reduce the economic burden from cancer cases
(ACS, 2010).
Definition of Cancer
The Merck Manual of Medical Information (2003) defines cancer as “a group of
cells (usually derived from a single cell) that has lost its normal control mechanisms and
thus has unregulated growth” (p. 1031). This unregulated cell division can spread to any
part of the body, including carcinoma, sarcoma, leukemia, lymphoma and myeloma, and
the central nervous system (The Merck Manual of Medical Information, 2003). The
development of cancer, or carcinogenesis, involves damage to cells’ DNA. When the
DNA-damaged cells are not protected by normal biological mechanisms, the mutated
cancerous cells multiply and form a neoplasm, or tumor, which is a new and abnormal
formation of tissue that has no useful function in the body. Tumors can become invasive
3

and harm surrounding tissues and organs, and eventually spread to distant tissues, which
is metastasis.
Carcinogenesis is described in three progressive phases. Phase one is initiation
and involves transformation of cellular DNA caused by interactions with external factors
(chemicals, radiation, or viruses and other infectious agents such as Helicobacter pylori
bacteria) or internal factors (inherited mutations, metabolic mutations, hormones, or
immune occurrences). The cellular transformation is rapid but remains dormant until
activated by a promoting agent. Ten years or more may pass between exposure to
external factors and detectable cancer (ACS, 2012). External and internal factors can act
together or in sequence to initiate or promote carcinogenesis. The second phase is
promotion, and the initiated cells multiply to form a tumor. Phase three is progression,
which leads to the cancer progressing to malignant tumors that have the ability to invade
and disrupt normal functions of tissues and organs, causing much harm to the body.
Nutrition can modify carcinogenesis at any phase including cellular protection, cell
differentiation, and tumor growth but the exact biochemical mechanisms are unknown
(Grant, 2008). Also, the nutritional status of a person with cancer is adversely affected by
carcinogenesis; tumor growth and medical treatment of cancer both have a negative
impact on one’s nutritional status.
Cancer symptoms are not always detectable, but unsubtle symptoms such as
excessive fatigue, nausea, loss of appetite, unexplained weight loss, and localized pain
should be treated as warning signs for cancer (ACS, 2012). Screenings such as
mammograms, tests such as tissue biopsies and serum markers that indicate cancer cells
in blood, and physical examinations are methods used to diagnose cancer. When cancer is
detected, it is assigned a stage using scans or other imaging tests. Cancer staging
4

describes the extent of the cancer at the time of diagnosis in regards to the primary
tumor’s size and metastasis. Proper staging is essential for determining treatment and
assessing prognosis (ACS, 2012).
Cancer stages include stages I, II, III, and IV. Stages I, II, and III are determined
depending on the location and size of the tumor(s) with stage I having smaller tumors
than stages II and III. The cancer stage also depends on how rapidly the cancerous cells
are spreading to neighboring lymph nodes and/or organs. Stage IV indicates advanced
cancer disease and the original tumor has spread to one or more organs. Early cancer
detection is vital in order to prevent the growth and spread of cancer (ACS, 2012).
Cancer prevention is a topic that is of great importance. It is estimated that one
third of cancer cases could have been prevented through primary prevention: diet,
physical activity, and the elimination and/or limitation of smoking and alcohol
consumption (ACS, 2012). The ACS (2012) recommends consuming at least two and a
half cups (which is approximately five servings) of fruits and vegetables daily because
high intakes of fruits and vegetables have been shown to reduce the risks of cancer.
Additionally, Shin et al. (2002) observed a reduced risk in breast cancer in
premenopausal women who consumed more low-fat, fat-free dairy products containing
vitamin D and calcium. This may indicate a large portion of the population may be
helped through the modification of diet, especially by obtaining adequate intakes of
calcium and vitamin D.
Calcium
Calcium is the most abundant mineral in the body and comprises 1.5% to 2% of
the body weight and 39% of total body minerals. In addition to being the main
5

component of bones and teeth, calcium is essential for a number of important metabolic
functions such as muscle contraction, nerve conduction, enzyme regulation, membrane
permeability, and blood clotting (Gropper, Smith, & Groff, 2009). Calcium activates
protein kinase C, which is an enzyme involved in a number of cellular functions such as
phosphorylating enzymes to activate or inactivate metabolic pathways (Gropper et al.,
2009). These regulations occur in the blood and cellular fluids within the cells of all
tissues. Only 1% of calcium exists in these locations, while the remaining 99% is in the
bones and teeth. When calcium is consumed and absorbed into the blood through the
intestinal mucosal cells, it is transported to cells or stored in the bones. Calcium is
retrieved from bone and returned to the blood and extracellular fluids as needed for
metabolic functions.
Calcium can be absorbed by two mechanisms in the small intestine: active and
passive transport. The active transport mechanism operates primarily in the duodenum
and proximal jejunum at low luminal concentrations of calcium ions. The passive
transport mechanism occurs in the entire length of the small intestine at high luminal
concentrations of calcium ions. About 30% of dietary calcium is absorbed by adults
whereas up to 75% is absorbed by children (Gropper et al., 2009). Calcium absorption
decreases with age due to diminished vitamin D production in the kidney; and
additionally, estrogen deficiency in postmenopausal women causes decreased vitamin Dmediated calcium absorption (Gropper et al., 2009). Active transport is controlled by the
action of vitamin D, while the passive transport mechanism is not controlled by vitamin
D. Vitamin D enhances the intestinal absorption of calcium by increasing calcium uptake
at the brush border of intestinal mucosal cells and stimulates the production of calbindins.
Calbindins are calcium-binding proteins that help store calcium ions temporarily after a
6

meal, and then transport them for the final step of absorption. Therefore, low vitamin D
intake or inadequate exposure to sunlight reduces calcium absorption.
Calcium absorption can be increased or decreased by a variety of food
compounds. To meet the dietary reference intakes for calcium (Table 1), the food items
that contain these compounds need to be known and adjusted in the diet. Calcium
supplements should be taken with a meal to enhance calcium absorption. Lactose also
enhances calcium absorption, even in adults with lactose intolerance. However, dietary
fiber can decrease calcium absorption if consumed in large amounts (more than 30
g/day). Oxalic and phytic acids also decrease the absorption of calcium by binding with it
and making calcium insoluble. Oxalic acid occurs in rhubarb, spinach, chard, and beet
greens, while phytic acid is on the outer husks of cereal grains. Not all dark green leafy
vegetables contain oxalic acid, such as kale, collards, turnip greens, mustard greens, and
broccoli. These vegetables are good sources of calcium along with small bones of
sardines, canned salmon, clams, oysters, and soybeans (Gallagher, 2008). Food sources,
serving sizes, and calcium amounts are listed in Table 2.
Table 1

Dietary Reference Intakes and Tolerable Upper Intake Levels for Calcium

Males and Females
Dietary Reference Intakes
Tolerable Upper Intakes
(age in years)
Calcium (mg/day)
Calcium (mg/day)
9-18
1300
2500
19-50
1000
2500
51 and older
1200
2500
Source: Institute of Medicine, Food and Nutrition Board (2011).
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Table 2

Selected Food Sources for Calcium

Food
General Mills, whole grain
Total cereal
Yogurt, plain, skim-milk

Serving Size

Amount of Calcium
(mg)

¾ cup

1000

8 ounces

452

Sardines, Atlantic, canned in
3 ounces
oil, drained
Macaroni and cheese, frozen
1 package
entrée
Milk, low-fat, 1% milkfat with
1 cup
added vitamin A and D
Milk, nonfat, with added
1 cup
vitamin A and D
Spinach, frozen, chopped or
leaf, cooked, boiled, drained, 1 cup
without salt
Rice drink, unsweetened,
fortified with calcium and
8 fluid ounces
vitamin A and D
Cheese, Swiss
1 ounce
Kale, cooked, boiled, drained,
1 cup
without salt
Broccoli, cooked, boiled,
1 cup
drained, without salt
Figs, dried, uncooked
2 figs

325
323
305
299
291
283
224
94
62
62

Source: United States Department of Agriculture (2011a).
Adequate intakes of calcium are vital to an individual’s health. A prolonged
inadequate intake of calcium may be a contributor to several chronic diseases such as
osteoporosis, colon cancer, hypertension, and obesity (Gropper et al., 2009). However, if
calcium intake is abnormally high, then there is an increased risk of hypercalcemia,
which can lead to excessive calcification in soft tissues, especially the kidneys.
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Vitamin D
Vitamin D is also known as calciferol and is classified as a prohormone (Institute
of Medicine, Food and Nutrition Board, 2011). Two major forms of vitamin D are
vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol). Vitamin D3 is produced in
the body after receiving solar ultraviolet B (UVB) radiation and the most active form of
vitamin D3 is calcitriol (Institute of Medicine, Food and Nutrition Board, 2011). Vitamin
D2 is produced in a variety of plant materials and yeast that received UVB radiation
(Bikle, 2009). Ergocalciferol is also the type of vitamin D that is usually used to fortify
foods such as milk and other products (Martini & Wood, 2006).
Vitamin D can be obtained through sunlight, foods and beverages containing
vitamin D, and supplements. Martini and Wood (2006) state that direct sunlight exposure
is the primary source of vitamin D for humans. Lack of sun exposure, type and/or
quantity of clothing, excess sunscreen, or type of melanin can lead to vitamin D
deficiency (Martini & Wood, 2006). Geographic location and ethnicity can determine
skin pigmentation. Skin coloration is determined by the pigmentation component
melanin. Two types of melanin are pheomelanin and eumelanin. Pheomelanin is the light
red-yellow skin pigmentation and this skin color is related to a higher risk of skin cancer.
Eumelanin is the brown-black skin pigmentation (Sherer & Kumar, 2010). On average,
African Americans have half the amount of vitamin D serum levels as white Americans
(Harvard Medical School, 2008). It is also known that latitude, season of the year, and
time of day are major contributors to vitamin D3 production in the human body (Martini
& Wood, 2006). Furthermore, as early as 1941, research determined a correlation in
latitude and cancer mortality (Giovannucci et al., 2006). Shwartz and Hanchette (2006)
observed that people living above 40 degrees latitude with less non-winter months are at
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a higher risk for vitamin D deficiency. The recommended daily allowance (RDA) of
vitamin D for 1 to 70 year-old individuals is 600 IU/day (15 mcg/day). People over the
age of 70 should consume 800 IU (20 mcg) of vitamin D daily (Table 3). The RDAs for
vitamin D are based on minimum sun exposure (Institute of Medicine, Food and
Nutrition Board, 2011).
Table 3

Dietary Reference Intakes and Tolerable Upper Intake Levels for Vitamin D

Males and Females
(age in years)

Dietary Reference Intakes
Tolerable Upper Intakes
Vitamin D (IU and mcg/day) Vitamin D (IU and
mcg/day)
9-70
600 IU, 15 mcg
4000 IU, 100 mcg
71 and older
800 IU, 20 mcg
4000 IU, 100 mcg
Source: Institute of Medicine, Food and Nutrition Board (2011).
The UVB radiation wavelength is 200-315 nm for sunlight and is the wavelength
required for the body to produce active vitamin D. Tanning beds and other artificial lights
start at 315 nm and rise to 400 nm, and therefore are not a source for vitamin D. Topical
sunscreens containing as little as sun protection factor (SPF) 15 absorb 99% of the
incident UVB radiation; and therefore, when SPF 15, or higher, sunscreen is applied on
the skin, only 1% of potential vitamin D is absorbed and synthesized (Holick & Chen,
2008). Also, excessive exposure to sunlight does not result in vitamin D intoxication
because sunlight destroys any excess vitamin D3 (Holick, 2007a).
Most foods in the United States that contain vitamin D are fortified because few
foods naturally contain vitamin D. Foods that contain vitamin D include fish oils such as
cod liver oil and oily fish (i.e., salmon, mackerel, and herring). Holick and Chen (2008)
reported that 3.5 ounces of wild-caught salmon had an average of 500-1,000 IU of
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vitamin D while farm-raised salmon only contained 100-250 IU of vitamin D for the
same serving size. Selected vitamin D sources are shown in Table 4.
Vitamin D deficiency can lead to a variety of health issues. Rickets in children is
the most known vitamin D deficiency and characterized by growth retardation, failure of
bone tissue to mineralize, bone deformations, and seizures (Gropper et al., 2009). Rickets
relation to vitamin D was discovered in the late 19th and early 20th centuries (Rajakumar,
2003). While rickets is rare today, vitamin D deficiency is not. Holick (2005) stated that
vitamin D deficiency is an epidemic in the United States caused mainly by avoidance of
sun exposure to the skin. Sensible sun exposure is recommended as 5 to 15 min/day
between 10 AM and 3 PM on arms and legs or hands, face, and arms during the spring,
summer, and fall seasons and provides the body with approximately 1000 IU (Holick,
2005). Vitamin D deficiency plays a major role in the development of chronic illnesses
such as cancer, cardiovascular diseases, autoimmune diseases, and infectious diseases
(Holick, 2007a), in addition to bone disorders. Therefore, it is vital to receive the
recommended daily amounts of vitamin D.
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Table 4

Selected Food Sources for Vitamin D.

Food
Swordfish (cooked)
Trout, rainbow, farmed
(cooked)
Salmon, Sockeye
(cooked)
Liver, beef, cooked
Tuna fish, canned in water
Milk (non-fat, reduced-fat,
and whole, vitamin D
fortified)
Rice drink, unsweetened,
fortified with calcium and
vitamin A and D
General Mills, whole grain
Total cereal
Sardines, Atlantic, canned in
oil, drained
Egg yolk
Cheese, Cheddar

Common Serving Size

Amount of Vitamin D (IU)

4 ounces

706

3 ounces

645

3 ounces

447

3 ounces

164

3 ounces

154

1 cup

115-124

8 fluid ounces

101

3/4 cup

100

3 ounces

46

1 large

41

1 ounce

7

Cheese, Swiss
1 ounce
6
Source: United States Department of Agriculture (2011b).
The best indicator of vitamin D status is the serum concentration of 25hydroxyvitamin D (25(OH)D) because it not only reflects vitamin D obtained through
food and supplements, but also vitamin D produced endogenously. Serum levels less than
30 nmol/L of 25(OH)D are associated with vitamin D deficiency. Serum levels of 30-50
nmol/L of 25(OH)D are considered inadequate for bone and overall health, while levels
greater than 50 nmol/L are considered adequate for bone and overall health in healthy
individuals. If 25(OH)D serum levels exceed 125 nmol/L, then there is a potential for
adverse effects (Institute of Medicine, Food and Nutrition Board, 2011).
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As shown in Figure 1, solar UVB photons enter the skin during sun exposure and
are undertaken by 7-dehydrocholesterol. The unstable pre-vitamin D rapidly binds to a
vitamin D-binding protein to begin the metabolic change. Vitamin D3 (cholecalciferol)
and vitamin D2 (ergocalciferol) undergo the same metabolic change. They are transferred
to the liver and metabolized by vitamin D-25-hydroxylase enzyme (CYP27A1 or 25OHase) into 25(OH)D, or calcidiol. Calcidiol is a substrate and used for production of
active 1,25-dihydroxyvitamin D, or calcitriol. The P450 family enzyme 25hydroxyvitamin D-1-a-hydroxylase is mainly in the kidney and acts in the final stages of
activation of 1,25(OH)2D (Martini & Wood, 2006).

Figure 1

Pathway to the active form of vitamin D.

Vitamin D has many roles in promoting overall good health. In addition to
vitamin D’s role in bone formation, mineralization, and growth by increasing calcium
absorption, it helps reduce inflammation and increase muscle strength and immune
function (Lips, 2006). Vitamin D participates in regulating cell growth and differentiation
as well (Samuel & Sitrin, 2008). Holick (2004) reported that 1,25(OH)2D is one of the
13

most potent regulators of cellular growth in normal and cancer cells. Several studies have
indicated strong associations between vitamin D and calcium and cancer and other
diseases (Peterlik & Cross, 2005). By meeting recommended daily amounts of vitamin D
(through diet and/or skin exposure to the sun) and calcium, the risk for common types of
cancers may be decreased (Heaney, 2003; Holick, 2005).
Vitamin D and Calcium and Cancer
Recent evidence suggests that vitamin D plays a role in breast cancer prevention
and survival rate (Hines, Jorn, Thompson, & Larson, 2010). Also, Rosling, Hebert,
Murphy, Davis, and Steck (2010) observed that women diagnosed with aggressive and
late stage breast cancer were more likely to have low levels of vitamin D compared to
women with less severe forms of breast cancer. Learning how people receive their RDA
for vitamin D is important in developing nutrition education programs that promote
adequate intakes of vitamin D. Sahota et al. (2008) determined the validation of a
questionnaire used in a population-based case-control study of breast cancer and vitamin
D by using telephone interviews in regards to vitamin D in relation to the circulation of
serum 25(OH)D. Two study sessions were used for this research. The winter and summer
sessions had 213 and 203 participants, respectively. All participants were interviewed on
vitamin D intake that included time spent outdoors, food, and supplements. They were
asked to provide blood samples within the next two-week period. Milk consumption,
outdoor activity (minimum of one hour), and the use of vitamin D supplements
significantly increased serum 25(OH)D levels for winter and summer (Sahota et al.,
2008).
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A case control study in 1998 obtained DNA samples from 425 females after
administering individual 45-minute telephone interviews covering breast cancer risk. The
purpose of the study was to determine the relationship between vitamin D receptor
(VDR) polymorphism and breast cancer risk. Significant results were not observed
between the VDR genotype and increased risk for breast cancer. This outcome proposes
that the VDR polymorphism would probably not be linked to breast cancer risk (Bérubé
et al., 2005).
The relationships of breast density in premenopausal and postmenopausal women
with vitamin D and calcium intakes through food and supplements were studied by
(Bérubé et al., 2005). The 777 premenopausal and 783 postmenopausal women were
asked to complete food questionnaires that provided a detailed history of vitamin D and
calcium consumption. Following the questionnaire, breast density was determined for
each participant through mammogram screenings. Results indicated that premenopausal
women with higher vitamin D and calcium intakes had decreased breast density, but this
did not occur in the postmenopausal women. Since lower breast density is associated with
lower breast cancer risk, the authors concluded that there may be a link between
increasing vitamin D and calcium intakes and decreasing breast cancer risk (Bérubé et al.,
2005).
Women (n = 1183) that were in the Health, Eating, Activity, and Lifestyle
(HEAL) study were asked by Neuhouser et al. (2008) to complete a 24-month follow-up
questionnaire, and to allow for their blood, weight, and height to be taken. All data were
analyzed and used for the cohort study except participants with no archived blood
specimens, which left 790 participants for data analysis. Almost 60% of the participants
were non-Hispanic whites. African Americans and Hispanics composed 26.5% and
15

11.4% of the participant sample, respectively. The participants’ mean age was 57.3 years,
and 62.3% of them were classified as overweight (Neuhouser et al., 2008). Overweight
was defined as a body mass index (BMI) of 25.0-29.9 kg/m2 per the National Institutes of
Health (NIH) guidelines (NIH, 2011). The mean vitamin D intake was only 4.0 mcg/day.
Approximately 25% of the participants used either a single vitamin D supplement or a
vitamin D-specific supplement such as vitamin D plus calcium (Neuhouser et al., 2008).
Neuhouser et al. (2008) compared serum 25(OH)D levels in each racial-ethnic
group by season and geographical location. They found that geographical location had a
more significant impact on serum 25(OH)D levels in the participants than the seasons.
They secondly determined serum 25(OH)D levels and breast cancer stage of disease link.
Women with in situ disease had a higher concentration of serum 25(OH)D than women
with localized or regional cancer. Neuhouser et al. (2008) also observed a significant
inverse relationship between increasing BMI and serum 25(OH)D.
The Cancer Prevention Study-II (CPS-II) Nutrition Cohort was established in
1992 and involved approximately 200,000 people answering surveys about medical,
dietary, reproductive, and lifestyle variables. Over 500 participants from the CPS-II
participated in the nested case-control study (McCullough et al., 2009). All 516
participants represented the postmenopausal breast cancer cases, as well as the controls.
All but two participants were matched to a control that had a birthday within six months
of them, the same race/ethnicity and date of blood collection. The purpose of the study
was to compare 25(OH)D concentrations between the postmenopausal breast cancer
cases and their controls. After data analysis, the season, current BMI, recreational
physical activity, and total vitamin D intake were determined to be predictors of
25(OH)D among participants. The summer months compared to winter months showed a
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higher concentration of 25(OH)D, as well as higher outdoor recreational physical
activity. The second analysis included the odds ratio (OR) and 95% confidence intervals
(CI) for the associations between 25(OH)D and postmenopausal breast cancer risk; the
results concluded no significant results (McCullough et al., 2009).
McCullough et al. (2009) also did not find any associations between 25(OH)D
and breast cancer risk from the history of postmenopausal hormonal therapy, BMI,
weight gain, ‘warm’ and ‘cool’ season of blood draw, or calcium intake. Latitude and
individual vitamin D supplements were the only significant observed interactions.
Women who were living at 37° or greater latitude had a significantly lower OR (0.35)
than women living at less than 37° (1.07) (McCullough et al., 2009). The shaded area in
Figure 2 represents the locations that are greater than 37° degrees latitude in the United
States (Harvard Medical School, 2008).

Figure 2

Division of the United States by the 37º Latitude. Source: Harvard Medical
School (2008).
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Newcomb et al. (2002) tested for an association between the VDR polymorphism
TaqI and breast cancer risk. They collected 532 cases from the Wisconsin statewide
cancer registry from January to December 1998. The cases included women aged 20-60
years that were identified with invasive breast cancer. Five hundred and seventy females
were selected to be controls from a list of drivers who were less than 65 years old and
Medicare beneficiary files (ages 65-69 years). All participants were asked to complete a
structured 45-minute telephone interview that included breast cancer risk factors.
Following the interview, mouthwash samples were provided by participants and used for
DNA purposes. Registry files provided tumor stage information for cases. Newcomb et
al. (2002) did not find any significant associations between the VDR genotype and breast
cancer risk in relation to age, menopausal status, family history, multivitamin use, or
BMI. Although they did report that postmenopausal hormone users with a tt genotype
could be at decreased risk of breast cancer (Newcomb et al., 2002).
Ooi, Zheng, Stalgis-Bilinski, and Dunstan (2011) examined breast cancer
metastases in the bone. They found that the MDA-MB-231 breast cancer cell line
produces purely osteolytic lesions. In this case, deficiencies of both vitamin D and
calcium enhanced early tumor growth within the bone. To further their study, they
concentrated on how vitamin D deficiency affects breast cancer tumor growth not only in
the bone environment, but also in the mammary fat pad of a cell line (MCF-7). Their
intentions were to mix the osteolytic/osteosclerotic lesions. They performed their tests on
female nude mice. Mice were split into two dietary groups. They contained the same diet,
but with one different factor, vitamin D. One group was restricted completely of vitamin
D, while the other group was given the equivalent of vitamin D3 at 2,000 IU/kg. Each diet
was comprised of 0.79% calcium. After the mice completed six weeks on their specified
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diet, they were randomized into two treatments groups: vitamin D sufficient and vitamin
D deficient. A slow injection of 5 x 104 cells/10 μl of cell suspension was performed
through the anterior tuberosity of the proximal tibia in both limbs. X-rays were taken of
the hind limbs 10 days after this procedure and again at 14, 21, and 28 days. Mixed lytic
and sclerotic bone lesions were produced by the subcutaneous implantation of 100 µl of a
concentration of 2 x 107 MCF-7 breast cancer cells into the mammary fat pad. Tumor size
was measured in three dimensions by calipers to determine tumor volume every second
day and by tumor weight at euthanasia on day 20 (Ooi et al., 2011).
A second procedure was conducted on the mice to determine osteoclastindependent effects of vitamin D on tumor growth in bone. Three days prior to intra-tibial
inoculation of breast cancer cells, each set of treatment groups was concurrently treated
with 1 mg/kg/day of OPG-Fc subcutaneous. The tibiae were removed in order to obtain
histological analyses. The blood was taken either retro-orbitally after six and eight weeks,
or via cardiac puncture after 10 weeks to determine vitamin D levels (Ooi et al., 2011).
Ooi et al. (2011) concluded that 1,25(OH)2D3 acts as an inhibitor when exposed to
MCF-7 breast cancer cells in vitro. The VDR mRNA was increased by approximately 8fold after MCF-7 cell cultures were exposed to 1,25(OH)2D3 for eight hours. Results
were also observed for vitamin D’s role in MCF-7-induced mixed osteolytic and
osteosclerotic lesions in the bone. The X-rays from the mice’s removed tibiae determined
that the vitamin D deficient mice showed more extensive osteosclerotic and osteolytic
bone lesions when compared to vitamin D sufficient mice. On the 21st day, vitamin D
deficient mice demonstrated a 27.7% larger sclerotic lesion area than in the vitamin D
sufficient counterparts, and on the final testing day (day 28), they remained at 12.8%
larger. Once they included the osteolytic lesion area with the sclerotic lesion area, the
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investigators found that the total lesion area in vitamin D deficient compared to vitamin
D sufficient mice were 40.1% and 20.6% larger at days 21 and 28, respectively. Ooi et al.
(2011) also reported that the formation of mixed osteosclerotic-osteolytic lesions is
dependent on bone turnover activity regardless of vitamin D levels. They determined that
vitamin D did not affect tumors in the mammary fat pad. Vitamin D’s benefits in
protecting against MCF-7 breast cancer cell metastasis are localized in the bone (Ooi et
al., 2010; Ooi et al., 2011).
Peng, Hawthorne, Vaishnav, St-Arnaud, and Metha (2009) reviewed the functions
regarding 25(OH)D3 in breast cancer cell proliferation. Their research begins with the
CYP27B1 protein. After reviewing this key enzyme’s involvement in the activation
process of the inactive 25(OH)D3 into active 1,25(OH)2D3, they began to further
investigate. They found that CYP27B1 has been detected in MCF-7 and T47D breast
cancer cells. Due to these findings of CYP27B1 being centralized to the epithelial cells in
breasts, Peng et al. (2009) hypothesized that 25(OH)D3 has chemopreventive effects at a
physiological concentration on the expression of 1 alpha-hydroxylase. Mouse mammary
organ culture (MMOC) was used to perform this research. Mammary gland organs were
cultured with different processes to produce either mammary alveolar lesions (MAL) or
mammary ductal lesions (MDL). This process differed upon steroid hormone
combination present in the provided medium. Vitamin D metabolites, which included 1alpha(OH)D3, 25(OH)D3, and 1,25(OH)2D3, were added to the glands for either day 0 to
day 4 (initiation phase), or day 4 to day 10 (promotion phase). During this time, MAL or
MDL developed. The glands were incubated for 14 additional days with a medium
containing only insulin in order to allow the regression of only normal structures. After
analysis of MMOC, the mouse mammary ductal epithelial cells showed extensive
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staining for 1alpha-hydroxylase regardless of the treatments. The ductal lesions treated
with 25(OH)D3 displayed the most intensive staining. The staining suggest that
25(OH)D3 inhibits the promotion stage of lesion formation and could serve as a non-toxic
natural chemopreventive agent for breast cancer prevention (Peng et al., 2009).
A qRT-PCR analysis was performed to determine if 25(OH)D3 regulates
CYP27B1 at the organ level. In order to obtain this data, T47D was cultured in MEM
containing 10% FBS and supplemented with non-essential amino acids with antibiotics.
The serum concentration of the cells was decreased to 2% after 70% confluence was
reached. The T47D cells were then treated with vitamin D metabolites for 24 hours and
qRT-PCR analysis was completed on the samples. CYP24 was used as a control gene in
this experiment because it is a direct target gene of vitamin D. CYP24 was significantly
increased by 2100-fold after a 24-hour treatment with 250nM 25(OH)D3. The CYP27B1
expression was increased by 2.2 fold during the same time. These results supported their
data of CYP27B1 regulation by 25(OH)D3 (Peng et al., 2009).
Peng et al. (2009) also questioned 25(OH)D3’s direct interaction with VDR
(without conversion to 1,25(OH)2D3). MMOC using mammary glands isolated from
CYP27B1KO mice were conducted to provide results on paired comparisons in order to
decrease the variance in the results. As in the previous experiment, CYP27B1KO glands
were treated for 24 hours with 250 nM 25(OH)D3. CYP24 was tested with both the
inactive and active forms of vitamin D3. Both experiments observed an increase in
CYP24 mRNA expression. The findings conclude that the inactive form of vitamin D3
directly affects VDR activation. These results were further tested by determining the
direct interaction between 25(OH)D3 and VDR. In this case, T47D breast cancer cells
were treated with clotrimazol (a specific 1 alpha-hydroxylase inhibitor). It was concluded
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that CYP24 is induced when 25(OH)D3 binds with VDR, although this is not as strong of
a reaction as with the active vitamin D3 (Peng et al., 2009).
Experiments were conducted to determine the efficacy of 25(OH)D3 in
comparison to 1,25(OH)2D3 using MMOC. MAL (hormone-independent) had a 75%
incidence rate after 7,12 dimethylbenz[α]-anthacene (DMBA) treatment. Once MAL
glands were incubated with 100 nM and 500 nM 25(OH)D3, they resulted in 61.2% and
57.3% suppression, respectively. Although, 1,25(OH)2D3 at 100 nM resulted in 82%
suppression. These results support that efficacy was higher in 1,25(OH)2D3, but
25(OH)D3 is completely physiological and non-toxic unlike its active form. The
25(OH)D3 was also evaluated for its efficacy performance for MDL (hormonedependent) that was also induced by DMBA. A 58.9% MDL incidence rate was inhibited
by 25(OH)D3. Therefore, the inactive form of vitamin D3 inhibits precancerous lesion
formation due to DMBA (Peng et al., 2009).
Knight, Wong, Blackmore, Raboud, and Vieth (2009) were concerned with the
influence of 25(OH)D and levels of estradiol and progesterone in women of menstrual
cycling age. They hypothesized that normal variation in serum 25(OH)D could influence
breast cancer risk via its relationship with estradiol and progesterone. The relationship
between 25(OH)D and these hormones was studied during the luteal phase in women
who were aged 18-22 years and not using hormonal contraceptives. To establish a normal
variation of 25(OH)D, they took blood samples during the summer months and during the
winter months (both before and after vitamin D supplementation). A total of 101 women
were tested at baseline, while only 37 participants provided blood samples and took four
weekly doses of 28,000 IU of vitamin D3 in the winter. Blood samples for all participants
were taken at approximately day 21 (determined by the onset of the previous menstrual
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period). Winter participants provided their second blood sample approximately 28 days
following the first sample. The 25(OH)D levels of the winter participants were analyzed
and compared to the summer participants’ blood levels. The highest serum 25(OH)D
levels among the winter participants were lower than the highest levels observed in the
summer participants. The mean level of 25(OH)D increased 44 nmol/l after supplement
use. The means for progesterone and estradiol concentrations after vitamin D
supplementation consisted of 7 and 28 nmol/l decreases, respectively. These findings
suggest that vitamin D may play a role in decreasing breast cancer risk through its role in
decreasing estradiol and progesterone in the blood stream (Knight et al., 2009).
According to Brinkman et al. (2011), calcium can contribute to the development
of precipitates/calculi, which can influence the pH of the urine and interact with other
urine components. This has led to the belief that certain calcium forms may increase the
risk of bladder cancer. Brinkman et al. (2011) wanted to advance these findings by
performing a population-based case-control study on bladder cancer risk. Their study was
conducted in Belgium and consisted of 200 bladder cancer cases (confirmed transitional
cell carcinoma) and 386 healthy control participants. Each participant received a
validated food frequency questionnaire (FFQ) with 322 food items linked to the
combined contents of three existing food tables focusing on the Belgian population.
Participants reported their usual dietary intakes for the prior annual cycle in scheduled
home interviews. Medical history, lifetime smoking history, family history of bladder
cancer, and 20-year residential and lifetime occupational histories were also obtained.
The FFQ contained nine categories for frequency of food consumption: never/seldom, 13 day/month, and 1, 2, 3, 4, 5, 6, or 7 days/week. Additional questions provided answer
options of (almost) never, sometimes, 50% of the time, most of the time, (almost) always.
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This provided a fixed response format for the majority of the FFQ. The final questions
included information about portion sizes and/or food supplement intake, such as vitamins
and minerals, which were open-ended questions. Brinkman et al. (2011) observed
participants with the lowest intake of magnesium, but the highest intakes of calcium and
phosphorus had statistically significantly higher odds of bladder cancer. Those with the
lowest intake of vitamin D had increased odds for bladder cancer risk (Brinkman et al.,
2011).
A prospective cohort study by Terry, Baron, Bergkvist, Holmberg, and Wolk
(2002) observed 61,463 women for approximately 11.3 years. A 67-item FFQ and Cox
proportional hazards model were used to estimate rate ratios and 95% confidence
intervals of the 572 incident cases of colorectal cancer observed during the follow-up
time period. They found an inverse relationship between dietary calcium intake and
colorectal cancer risk. A reduced risk of colorectal cancer was seen in women with the
highest calcium intake (median 914 mg/day). Women with the lowest reported calcium
intake (median 486 mg/day) had an increased risk for colorectal cancer (Terry et al.,
2002).
Wu, Willett, Fuchs, Colditz, and Giovannucci (2002) also observed a relationship
in increased calcium intake and reduced risk for colorectal cancer. Their study examined
two prospective cohorts, the Nurses’ Health Study (NHS) and the Health Professionals
Follow-up Study (HPFS). The study population included 87,998 women in the NHS and
47,344 men in the HPFS. The participants completed a FFQ and provided a medical
history and lifestyle factor information at baseline. The follow-up occurred at least every
four years and during this time, the participants’ dietary information was updated.
Between baseline (1980 for NHS and 1986 for HPFS) and the end of the follow-up in
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1996, there were 626 female and 399 male colon cancer cases identified. When
considering men and women together, they found an inverse association between higher
total calcium intake and distal colon cancer. The study also showed that there may not be
an association with calcium intake beyond moderate levels and colon cancer risk
reduction (Wu et al., 2002).
A Japanese case control study by Kawase et al. (2010) examined the association
between vitamin D and calcium intake and breast cancer risk depending on menopausal
status. Individual roles of vitamin D and calcium as well as their interactive affects were
analyzed. A total of 5,409 female patients from the Aichi Cancer Center Hospital served
as cases (n = 1,803) and controls (n = 3,606) for this study. All participants were
randomly selected. Cases and controls were randomly matched by age (within 3 years of
age) and menopausal status (pre or postmenopausal) in a 1:2 (case:control) ratio.
Participants with high BMI, low daily physical activity, and a family history of breast
cancer were significantly greater in cases than controls. Lifestyle habits, medical and
food histories, and vitamin and mineral levels were obtained through FFQ, blood
samples, and medical records. The FFQ reveal that milk, yogurt, tofu, bone-edible small
fish, potato, green leafy vegetables, and light-colored vegetables are the main calcium
contributors for Japanese people. As for vitamin D intake, fish and bone-edible small fish
are solely responsible. Vitamin D and calcium intakes were inversely associated with the
overall risk of breast cancer. Premenopausal participants with increased vitamin D levels
showed a significant correlation in the decrease of breast cancer risk; however,
postmenopausal participants’ risk was decreased significantly by calcium intake (Kawase
et al., 2010).
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Peterlik and Cross (2005) stated that evidence from clinical trials and
observational studies support the hypothesis that calcium malnutrition and
hypovitaminosis D increase the risk for malignancies, especially colon, breast, and
prostate cancers. Holick (2005) further summarized that studies revealed if serum
25(OH)D levels were 20 ng/ml or higher, there was an approximate 30% to 50%
decreased risk of developing and dying from colon, breast, and prostate cancers. Harris
and Go (2004) reported that calcium supplementation can reduce the recurrence of colon
polyps but the effect was dependent on serum vitamin D levels. They concluded that with
the apparent synergistic effect of calcium and vitamin D, supplementation of both
nutrients in cancer prevention programs may be advisable (Harris and Go, 2004).
Dietary calcium and vitamin D may have profound effects on cancer risk. The
current study investigated cancer participants’ intakes of foods high in vitamin D and
calcium, use of supplements, and attitudes and perceptions of eating healthy compared to
participants who reported not having cancer. A cancer treatment center in Montgomery,
Alabama was used for data collection. The cancer incidence rates for Montgomery
County, Alabama, in comparison with the United States are shown in Figure 3.
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Figure 3

Montgomery County, Alabama, vs. United States Cancer Incidence Rates,
2004-2008. Source: National Cancer Institute, National Institutes of Health
(2010).
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CHAPTER III
METHODOLOGY
Participants
The intent of this study was to determine cancer-diagnosed participants’ attitudes
about foods high in vitamin D and calcium, and their determination to eat healthy
compared to participants that did not have cancer. The Montgomery Cancer Center in
Montgomery, Alabama was used to recruit participants in April 2011. All employees,
patients, and friends and families of the patients that were in attendance at the
Montgomery Cancer Clinic were given the option of completing a survey if they were 18
years old or older (Appendix A). This study used a convenience sample. Both groups,
participants diagnosed with cancer and participants in the control group (those who
identified themselves as not having cancer), voluntarily chose to complete the survey. At
the clinic, those who did not want to participate were not treated differently than those
who participated. There were no parameters other than being at least 18 years old that
caused a person to not be considered for this study.
Data Collection
Participants were allowed to complete surveys in the waiting rooms and while
taking treatments, although they were not required to answer all items in the
questionnaire. All questionnaires were enclosed in manila envelopes. Each participant
was asked to place their completed questionnaire back into the envelope to assure the
anonymity of the participants. The questionnaire did not ask for personal information
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other than general demographics (Appendix A). This study did not interfere with the
normal daily routines or violate the privacy of any participants at any time. When
participants returned the questionnaire to the researcher, they were given a handout
(Appendix B) that includes information about calcium and vitamin D from Harvard
Pilgrim Health Care (2005).
Survey Design
The questionnaire (Appendix A) was modeled from the National Cancer
Institute’s Diet History Questionnaire (2007). The National Cancer Institute (2011) states
that three separate studies assessed the validity of the questions on the Diet History
Questionnaire (Kipnis et al., 2003; Subar et al., 2001; Thompson et al., 2002). The
questionnaire used in the present study had a total of 54 items and seven of the items had
a dichotomous response format. A Likert scale was used to measure two subjective
summary questions, “In general, please indicate how much you agree or disagree with the
following statement: I have a healthy diet” and “… I try to eat healthy every day.” The
Likert scale ranked 1 as “disagree very much, 3 = neither agree nor disagree, 5 = agree
very much. The questionnaire also provided participants with four serving size-measuring
guidelines to help them provide the most accurate response to portion size questions.
Demographic (age, sex) data, menopausal status, and current cancer information
(currently have or do not have cancer, type of cancer, and the stage of cancer) were
collected. Calcium and vitamin D amounts were estimated based on weekly intakes of
supplements, sun exposure time (without sunscreen), and monthly food frequencies and
diet history (specifically foods high in calcium and/or vitamin D).
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Institutional Review Board Approval
The Institutional Review Board (IRB) through the Mississippi State University
(MSU) Regulatory Compliance Office, Mississippi State, Mississippi, approved this
study prior to the launch of the study as IRB #11-026 (Appendix C). The administrative
services from the Montgomery Cancer Center of Montgomery, Alabama, also approved
this study prior to starting the project and provided a letter of support (Appendix D) to the
MSU IRB. Approvals from both facilities were required in order to survey participants at
Montgomery Cancer Center onsite. Both MSU and Montgomery Cancer Center approved
this study in the winter of 2010.
Statistical Analysis
Data were analyzed using the Statistical Package for Social Sciences (SPSS)
version 18.0 (SPSS Inc., Chicago, Illinois) with statistical significance determined at the
0.05 level (p < 0.05). The survey data were analyzed to determine differences between
cancer and non-cancer participants’ dietary intakes and attitudes and perceptions about
their overall diets and intakes of vitamin D and calcium supplements. Comparisons
between the group diagnosed with cancer and the group that reported they did not have
caner were conducted using t-tests and chi square tests. Continuous variables are reported
as means ± standard deviations (SD).
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CHAPTER IV
RESULTS AND DISCUSSION
This study included 128 participants (94 females, 34 males) who were 18 – 91
years of age. The mean age of the overall group was 53.5 years ± 16.6. Mean age for
male participants was 59.6 years ± 14.7 (range of 27 – 90 years), while the females’ mean
age was 51.3 ± 16.8 (range of 18 – 91 years). The majority (53.9%, n = 69) of
participants did not have cancer and 59 participants (46.1%) had been diagnosed with
cancer. The mean age of the cancer participants was 60.9 ± 13.4 and the mean age of the
group without cancer was 47.1 ± 16.6 (Table 5).
Types of cancer reported by those with cancer included breast (30.5%, n = 18),
lung (18.6%, n = 11), colon or rectal (10.2%, n = 6), and various other types of cancer
such as prostate (n = 2), leukemia (n = 2), endometrial (n = 2), melanoma (n = 2), nonHodgkin lymphoma (n = 1), and several participants indicated they had more than one
type of cancer. Participants with cancer were asked if they knew what stage of cancer
they were currently diagnosed with and 44.1% (n = 26) indicated they did not know,
20.3% (n = 12) reported they were in Stage IV, 11.9% (n = 7) reported Stage II, 8.5% (n
= 5) reported Stage III, 6.8% (n = 4) reported Stage I, and five participants did not
respond.
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Table 5

Characteristics of All Participants, Participants with Cancer, and Those
without Cancer

Characteristics of
Participants
Age (years)
(age range)

All Participants
(N = 128)
53.5 ± 16.6a
(18–91)

Participants with
Cancer (n = 59)
60.9 ± 13.4
(27–90)

Participants without
Cancer (n = 69)
47.1 ± 16.6
(18–91)

Age Categories:
18 – 39
40 – 49
50 – 59
60 – 69
70 – 91

27b
21
27
28
20

5
5
14
9
14

22
16
13
19
6

Gender and Age:
Male
(age range)
Female
(age range)

59.6 ± 14.7 (n = 34)
(27–90)
51.3 ± 16.8 (n = 94)
(18–91)

62.5 ± 15.1 (n = 24)
(27–90)
59.9 ± 12.2 (n = 35)
(30–83)

52.9 ± 11.9 (n = 10)
(39–71)
46.1 ± 17.2 (n = 59)
(18–91)

a

Mean ± standard deviation
Number of participants

b

The overall response to the question, “In general, how concerned are you about
eating healthy?” resulted in a mean response of 4.4 ± 0.8 on a 5-point scale of 1 = very
unconcerned to 5 = very concerned. When comparing responses between participants
who had cancer and those without cancer, there was not a significant difference (p >
0.05) but most participants were concerned or very concerned about eating healthy (Table
6). An overwhelming majority (91.4%) of respondents with cancer indicated they were
concerned or very concerned with eating healthy, which was similar to responses
provided by those without cancer. Participants were also concerned about receiving their
daily requirements for vitamin D and calcium; a score of 4.2 ± 1.1 was obtained for all
participants, and there was not a significant difference between the two groups (Table 6).
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Table 6

Attitudes of All Participants, Participants with Cancer, and Those without
Cancer

Questionnaire Items

All
Participants
(N = 128)

Participants
with Cancer
(n = 59)

Participants
without cancer
(n = 69)
P valuea

In general, how concerned
are you about eating
healthy?

4.4 ± 0.8b

4.4 ± 0.9

4.3 ± 0.7

0.599

4.3 ± 1.2

4.2 ± 1.0

0.642

3.4 ± 1.1

3.0 ± 1.1

0.050*

3.4 ± 1.2c

3.7 ± 1.1

3.2 ± 1.3

0.048*

3.5 ± 1.1d

3.7 ± 1.1

3.4 ± 1.1

In general, how concerned
are you about receiving your 4.2 ± 1.1b
daily requirements for
vitamin D and calcium?
Indicate how much you
agree or disagree with the
3.1 ± 1.1c
following statement: I have
a healthy diet.
Indicate how much you
agree or disagree with the
statement: I try to eat
healthy every day.
How healthy is your diet in
general?

0.130

aP value is comparing the participants with cancer and those without cancer (t-test).
bMean ± standard deviation (1 = very unconcerned, 3 = neither concerned nor
unconcerned, 5 = very concerned). cMean ± standard deviation (1 = disagree very much,
3 = neither agree nor disagree, 5 = agree very much). d1 = my diet is very unhealthy, 2 =
my diet is somewhat unhealthy, 3 = my diet is neither healthy nor unhealthy, 4 = my diet
is somewhat healthy, 5 = my diet is very healthy. *Significant at p ≤ 0.05.
Participants were asked to respond to the item, “I try to eat healthy every day.”
The mean response for all participants was 3.4 ± 1.2 with cancer participants reporting a
higher value (3.7 ± 1.1) compared to participants without cancer (3.2 ± 1.3, p = 0.048,
Table 6). This may indicate that participants with cancer were trying to eat healthier than
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those without cancer. Participants with cancer agreed more with the item, “I have a
healthy diet” than those without cancer (p = 0.050) although the mean response of 3.4 ±
1.1 was between 3 = neither agree nor disagree to 4 = agree on the Likert scale (Table 6).
There was not a significant difference (p = 0.130) between the two groups for the item
that asked participants to choose the answer that best described how healthy they felt
about their diet in general. The responses ranged from 1 = my diet is very unhealthy to 5
= my diet is very healthy. Those with cancer had a mean score of 3.7 ± 1.1 and those
without cancer had a mean response of 3.4 ± 1.1 indicating they felt their diet was neither
healthy nor unhealthy to somewhat healthy (Table 6).
Results comparing males and females discovered a difference (p = 0.042) for the
questionnaire item about being concerned for receiving the daily requirements for
vitamin D and calcium; women scored this item higher (4.4 ± 0.9) than men (3.9 ± 1.3).
This could be possibly due to osteoporosis awareness, which usually aims to increase
calcium and vitamin D intakes in women, more than men, to prevent osteoporosis.
However, cancer treatments such as chemotherapy, radiation, and some surgeries cause
adverse nutritional effects, which can be severe, in both males and females (Grant, 2008).
There were no other differences (p > 0.05) between males and females.
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Table 7

Selected Food Intakes by All Participants, Participants with Cancer, and
Those without Cancer
All Participants Participants
(N=128)
with Cancer
(n=59)
2.3 ± 1.2c
2.2 ± 1.3

Participants
without Cancer
(n=69)
2.4 ± 1.1

.412

3.0 ± 2.5

3.5 ± 2.7

2.6 ± 2.3

.058

2.3 ± 2.4

2.1 ± 2.3

2.4 ± 2.5

.453

3.3 ± 2.4

3.8 ± 2.6

2.8 ± 2.1

.012*

0.8 ± 1.5

0.9 ± 1.7

0.7 ± 1.4

.373

0.1 ± 0.8

0.2 ± 1.2

0.03 ± 0.3

.242

1.7 ± 1.3

1.8 ± 1.4

1.7 ± 1.3

.450

1.7 ± 2.0
Cereals, e.g., Total
Raisin Bran, Total
Corn Flakes, Whole
Grain Totale
1.5 ± 1.3
Salmon, tuna,
halibut, trout,
or swordfishe
0.5 ± 1.0
Sardines, clams,
or oysterse
Cooked leafy greens, e.g., 1.9 ± 1.6
turnip, collard, mustard,
kale, spinach, Swiss
chard, or Bok choye
2.1 ± 1.5
Broccolie

1.8 ± 1.8

1.6 ± 2.2

.521

1.5 ± 1.0

1.6 ± 1.5

.574

0.7 ± 1.2

0.3 ± 0.7

.036*

2.1 ± 1.6

1.7 ± 1.5

.179

1.7 ± 1.3

2.3 ± 1.6

.026*

1.0 ± 1.4

0.7 ± 1.2

1.2 ± 1.6

.081

1.5 ± 2.0

1.7 ± 2.0

1.4 ± 2.0

.444

Questionnaire Items
Overall dairy product
consumptionb
Milk fortified
with vitamin Dd
Yogurt fortified with
vitamin De
Juice fortified
with vitamin D
and/or calciumd
Soy, rice, almond, or
other “milks” fortified
with vitamin D and/or
calciumd
Tofu fortified
with calciume
Macaroni and cheesee

a

Raw leafy greens
(excluding lettuce)e
Dried fruits, e.g., figs,
prunes, raisinse

P valuea

P value is comparing the participants with cancer and those without cancer (t-tests).
Responses: 0 = none, 1 = less than one serving a day but one or two servings a week, 2 =
1 serving a day, 3 = 2 servings a day, 4 = 3 servings a day, 5 = 4 or more serving a day.
c
Mean ± standard deviation.
d
Responses: 0 = never, 1 = 1 time in past month, 2 = 2-3 times in past month, 3 = 1-2
times per week, 4 = 3-4 times per week, 5 = 5-6 times per week, 6 = 1 time per day, 7 =
2-3 times per day, 8 = 4-5 times per day, 9 = 6 or more times per day.
e
Responses: 0 = never, 1 = 1 time in past month, 2 = 2-3 times in past month, 3 = 1 time
per week, 4 = 2 times per week, 5 = 3-4 times per week, 6 = 5-6 times per week, 7 = 1
time per day, 8 = 2 or more times per day.
*Significant at p ≤ 0.05.
b
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There was not a significant difference (p > 0.05) between participants with cancer
and those without cancer in regards to overall consumption of dairy products (Table 7).
Although 27.2% of all participants indicated they never drank milk in the past month,
24.0% drank milk at least one time per day. Almost 65.0% of participants consumed 1 –
3 servings of dairy products everyday over the past month. The examples of dairy
products and servings consumed by participants were 1 cup of milk, ½ cup of ice cream,
1 cup of yogurt, and 1 ounce or slice of cheese. This entails that approximately 65.0% of
participants were consuming a minimum range of 224 – 452 mg calcium everyday and a
maximum range of 672 – 1,356 mg calcium everyday over the past month. Of the 34
participants who never consumed dairy products, 14 of them indicated the reason was
because they were lactose intolerant and another 14 indicated they just did not think
about drinking or eating dairy products.
More participants with cancer drank juice fortified with vitamin D and/or calcium
compared to participants without cancer, 3.8 ± 2.6 and 2.8 ± 2.1, respectively (p = 0.012,
Table 7). Approximately 26% of all participants drank juice fortified with vitamin D
and/or calcium at least once a day, while 43% drank it less than three times per month. Of
the participants who drank fortified juice (n = 51), almost 50% drank 1 – 1 ½ cups each
time. Less than 10% drank more than 1 – 1 ½ cups as a serving size. Participants were
also asked if they consumed fortified beverages other than juice such as almond, soy, or
rice milk. Approximately 71% of 121 respondents reported in the past month they had
never consumed these types of beverages and less than 3% of participants consumed
them daily.
Almost 40% of participants never ate yogurt fortified with vitamin D. Only 15.2%
consumed yogurt 2 – 3 times in the last month, while 12% consumed it 5 – 6 times each
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week. Of those who consumed fortified yogurt (n = 81), 65.4% ate less than a cup each
time. A vast majority, 96.6%, of participants did not eat tofu fortified with calcium in the
past month as indicated by the low mean score of 0.1 ± 0.8 (Table 7). Approximately
83% of participants ate less than three servings of macaroni and cheese monthly, while
less than 3% ate it daily. Over 50% of the participants that reported eating macaroni and
cheese (n = 105) reported they ate 1 – 1 ½ cups as a serving.
While there was not a significant difference in consumption of cooked leafy
greens between participants without cancer and those with cancer, those without cancer
indicated they ate broccoli more often than those without cancer, 2.3 ± 1.6 and 1.7 ± 1.3,
respectively (p = 0.026, Table 7). Almost 25% of participants (n = 123) reported they
never ate cooked greens such as collard, turnip, mustard, spinach, Swiss chard, Bok choy,
or kale, in the past month, but 50% reported eating these vegetables 1 – 3 times in the
past month. Over 50% of the participants ate 1 – 1 ½ cups as a serving size for cooked
greens. Of 120 respondents, 60% never ate raw greens during the past month and less
than 1% ate them one time per day. Almost 30% of all participants reported they ate less
than one cup of raw greens each time, while another 30% said they ate more than 1 – 1 ½
cups as a serving size. Over 50% of 124 respondents ate a serving of broccoli 1 – 3 times
in the past month and over 15% consumed broccoli 1 – 2 times a week and approximately
54% of 111 respondents ate a serving size of 1 – 1 ½ cups each time. There were not any
significant differences for consumption of raw leafy vegetables and dried fruit (p > 0.05).
Of the 124 respondents, 45.2% never ate dried fruits (i.e., figs, prunes, and raisins) in the
past month, and 33% ate them only 1 – 3 times in the past month.
The majority of participants ate sardines, clams, or oysters a maximum of one
time per month, if at all; however, those with cancer indicated they ate sardines, clams, or
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oysters more often than those without cancer (p = 0.036). Participants were asked, “How
many times in the past month did you consume salmon, swordfish, tuna, halibut or
trout?” Almost 60% of 123 respondents reported they consumed these items one to three
times in the past month. The majority of participants that reported they had consumed
these items in the past month also said they had on average eaten between 3 – 6 ounces
each time.
Almost 75% of 122 participants consumed General Mills Total cereal (i.e., Total
Corn Flakes, Total, or Total Raisin Bran) less than three times in the past month. Of 72
participants, 62.5% ate a serving size of 1 – 1 ½ cups each time. After being asked if they
consumed milk with their cereal, 96.2% responded, “Yes” and over 70% of participants
added 1 – 1 ½ cups of milk to their cereal. There was not a significant difference (p >
0.05) between participants with cancer and those without cancer in the number of times
in the past month they consumed Total cereal.
Twenty-five participants with cancer (42.4%) reported they took multivitamin
supplements and 32 participants without cancer (46.4%) took multivitamins (Table 8). Of
the 57 participants that did take a multivitamin, 78.9% took one every day. Almost 80%
reported their multivitamin also contained minerals. Fifty-eight participants reported
taking other supplements such as individual vitamins, minerals, and herbal supplements,
with similar numbers of users reported for those with cancer and those without cancer (p
= 0.622, Table 8). Overall, 60.3% of participants did not take antacids and of the 29.7%
that took antacids, 77.8% took two or less tablets or lozenges in one day. The majority of
participants (60.1%) reported never taking a calcium supplement. Approximately 70% of
those who indicated they took a calcium supplement reported that it contained vitamin D
as well. Only four males reported taking a calcium supplement that contained vitamin D,
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while 37 females reported taking a calcium plus vitamin D supplement. Only 10
participants with cancer (16.9%) took a vitamin D supplement while more participants
without cancer (33%, n = 23) took vitamin D (p = .001, Table 8). Approximately 75% of
participants did not take an individual vitamin D supplement, but 69.1% reported they
regularly exposed their skin to the sun for 10 to 15 minutes without sunscreen.
The current study indicated that approximately 25% of the participants did not
take a vitamin D supplement which was similar to the results reported by Neuhorser et al.
(2008). They reported approximately 25% of the participants used either a single vitamin
D supplement or a vitamin D-specific supplement such as vitamin D plus calcium
(Neuhouser et al., 2008). Additionally, Shin et al. (2002) observed a reduced risk in
breast cancer in premenopausal women who consumed more low-fat, fat-free dairy
products containing vitamin D and calcium, which supports the importance of obtaining
adequate amounts of vitamin D and calcium.
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Table 8

Supplement Intakes by All Participants, Participants with Cancer, and Those
without Cancer

Supplement
Multivitamin

Participants Participants
All Participants with Cancer without cancer
(N=128) Yes (n=59) Yes (n=69) Yes P valuea
Responses (n) Responses (n) Responses (n)
57
25
32
.750

Other supplements
58
(individual vitamins,
minerals, herbal
supplements)
Vitamin D supplement33

28

30

.622

10

23

.001*

Calcium supplementb 1.2 ± 1.8c

1.2 ± 1.8

1.2 ± 1.8

.973

Antacids, e.g.,
0.7 ± 1.2
0.7 ± 1.2
0.8 ± 1.2
.629
b
Tums, Rolaids
aChi-square tests determined differences between participants with cancer and those
without cancer for yes responses; t-tests determined differences between means.
bResponses: 0 = never, 1 = 1-3 days per month, 2 = 1-3 days per week, 3 = 4-6 days per
week, 4 = every day.
cMean ± standard deviation.
*Significant at p ≤ 0.05.
Over 50% of 123 respondents thought they usually obtained their daily
requirements of vitamin D and calcium, although less than 43% of 124 respondents
agreed or very much agreed to the statement, “I have a healthy diet.” Respectively,
41.1% and 17.7% agreed and agreed very much to the statement, “I try to eat healthy
every day.” When asked to choose which statement best reflects their diet, almost 50%
of 125 respondents chose “My diet is somewhat healthy.”
There were 56 postmenopausal women and 36 women that indicated they were
premenopausal. There were no significant differences (p > 0.05) between theses two
groups of women. More postmenopausal women reported taking a calcium supplement
that contained vitamin D than premenopausal women but it was not significant (p >
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0.05). These results could help build marketing campaigns for vitamin D and calcium
consumption. Today, the majority of marketing messages seem to target postmenopausal
women. Results from this study did not show any significant differences in eating habits
and dietary attitudes between pre and postmenopausal women; however, the sample size
was small. It may still be advisable to target both pre and postmenopausal women when
discussing intakes of vitamin D and calcium.
This study had limitations. One limitation of this study includes the location of
study participants. The study could have benefited by testing a variety of cancer clinics
from rural and urban locations throughout the southern United States. The results would
be more applicable to generalize to the southern population’s eating habits and dietary
concerns for vitamin D and calcium. Another limitation of the study was a lack of
questionnaire items that reflected interactions with vitamin D and calcium absorption
such as how often participants took anticonvulsant medicines, glucocortoicoids, HAART,
or antirejection medicications (Holick, 2007b). Also, participants should have been asked
to report if they had Crohn’s disease, whipple disease, cystic fibrosis, celiac disease, or
liver disease since these contribute to vitamin D deficiency (Holick, 2007a). These results
could have been used to determine if participants who took interacting medications and
supplements, or who had a malabsorption disease, were more concerned about their
vitamin D and calcium intakes than those who did not. African American females have
higher breast cancer rates (32.0%) than white females (22.8%) and Hispanic/Latino
(15.1%). African American males have a 33% higher death rate for cancer compared to
white males (ACS, 2011). Therefore, participants should have been asked their race due
to African Americans having higher cancer rates than white Americans (ACS, 2012).
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CHAPTER V
CONCLUSION
Not all types of cancer have increased annual rates, but cancer is still an epidemic
in the United States and the second leading cause of death. Cancer is estimated to be the
cause of more than half a million lives in 2012. The cost of cancer is great; in 2007 the
estimated cost of cancer was $226.8 billion, which included direct medical cost for all
healthcare expenditures for cancer ($103.8 billion), and indirect mortality cost of $123.0
billion (cost of lost productivity due to premature death caused by cancer) (ACS, 2012).
Cancer has directly cost Americans over $100 billion in 2010 alone (ACS, 2012).
Although some risk factors for cancers are uncontrollable such as age and genetics, other
risk factors that are controllable such as daily amount of physical activity and dietary
intakes should be modified to decrease the risk of cancer.
The ACS (2012) estimated that approximately one-third of cancer deaths are
related to physical inactivity, poor nutrition, and overweight or obesity. The
understanding of what is poor nutrition may be only vaguely understood for cancer
prevention, development, and treatment. Adequate amounts of vitamin D and calcium
have both been associated with reduced risk of cancer (Lappe et al., 2007). Vitamin D
and calcium can play a positive role in inhibiting the growth of mammary tumors as well
as increasing the cancer patient’s bone recovery and stability during and after treatments
(Neuhouser et al., 2008). Therefore it is important for cancer patients to receive the
recommended daily amounts of vitamin D and calcium.
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Cancer patients often experience changed eating behaviors from the side effects
of cancer therapy such as change in taste and smell, early satiety, nausea, odynophagia,
etc (ACS, 2012). These side effects can lead to dislikes of food in general, less desire to
eat and drink, and discomfort or difficulty eating and drinking. These factors could also
affect the cancer patient’s eating choices and patterns. Results from the current study
showed significant differences (p < 0.05) between the participants with cancer and those
without cancer for consumption of sardines, clams, or oysters; broccoli; and juice
fortified with vitamin D and/or calcium.
The findings from this research can be beneficial for the development of nutrition
education programs for cancer patients and/or cancer survivors. The findings showed that
over half of participants were very concerned with eating healthy and obtaining their
daily vitamin D and calcium requirements. Also, the participants with cancer and the
females were more concerned with eating healthy and obtaining the recommended daily
allowances of vitamin D and calcium than non-cancer participants and males. These
findings could help build a nutrition component into a cancer-spouse support program.
Further investigations with a nationally representative sample should be done prior to
incorporating these findings into nutrition education lessons.
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